Drug Type Bispecific antibody |
Synonyms- |
Target |
Mechanism CD3 inhibitors(T cell surface glycoprotein CD3 inhibitors), Globo H inhibitors(Globo H inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | CN | 13 Sep 2022 |